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The strongest risk factor for developing Alzheimer’s Disease (AD) is age. Here, we study the relationship
between ageing and AD using a systems biology approach that employs a Drosophila (fruitfly) model of AD
in which the flies overexpress the human Ab42 peptide. We identified 712 genes that are differentially
expressed between control and Ab-expressing flies. We further divided these genes according to how they
change over the animal’s lifetime and discovered that the AD-related gene expression signature is
age-independent.We have identified a number of differentially expressed pathways that are likely to play an
important role in the disease, including oxidative stress and innate immunity. In particular, we uncovered
two new modifiers of the Ab phenotype, namely Sod3 and PGRP-SC1b.
T
he phenomenon of protein aggregation has been associated with a variety of human disorders that affect
large sections of the population worldwide1–3. These disorders, which include Alzheimer’s, Parkinson’s, type
II diabetes, and the spongiform encephalopathies, are rapidly becoming one of themost important groups of
pathologies worldwide in terms of both incidence and social costs.
Alzheimers disease (AD) is the leading cause of dementia in the human population. At least for familial AD,
mutations that result in the generation of aggregation-prone isoforms of the amyloid b peptide are sufficient to
cause amyloid plaques in the brain and the clinical features of the disease.Mature amyloid plaques are always seen
in AD; however it is thought that precursor conformers, termed Ab oligomers, are of primary importance in the
pathology. It is becoming evident that, while the neuronal injury in AD is initiated by the accumulation of
neurotoxic aggregates of Ab peptide, these then give rise to a complex network of downstream events, (including
aggregation of the tau protein) that culminate in neurodegeneration3. Neither the complete list of pathways
involved in disease progression nor the causal chain of events that unites them is clear. It is therefore becoming
increasingly apparent that a paradigm shift is required in order to describe and rationalise this complexity. It may
simply not be possible to understand sporadic AD as the result of perturbations to a single pathway, where a single
cause leads to the effect. Rather, the disorder should be studied as a system; that is, a change in the homeostatic
equilibrium of many pathways4.
Ageing is a physiological process rather than just a chronological one. It is accompanied by changes in the
steady-state mRNA levels of a number of genes and in the levels of many proteins that are involved in a variety of
physiological processes5. A component of ageing is the collapse of cellular protein homeostasis and this process is
thought to underpin the increasing incidence of protein aggregation diseases in the elderly4,6. Indeed, age-related
changes in gene transcription lead to decreased quality control functions with age7. Late onset Alzheimer’s disease
accounts for the overwhelming majority8 of disease cases, making age the strongest risk factor for developing the
disease.
It follows that, in order to elucidate the underlying causes that trigger AD and affect its development, it is
necessary to investigate the changes in AD as a function of age. Here, we have used a Drosophila model of AD9 to
study how various cellular pathways (as measured by transcription profiling) change with age and AD. In this
model, the secreted human Ab42 peptide is expressed specifically in the central nervous system of Drosophila
melanogaster. The model recapitulates many of the pathologies observed in human AD, including Ab accumula-
tion, and premature death9–11. In the present study, we have used two versions of this model. For the transcriptomics
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study, we expressed the wild type Ab42 coding sequence whereas, for
gene-specific RNAi knock-down or over-expression experiments, we
extended our study by validating the original observations in flies
expressing the familial AD-linked Arctic (E22G) variant of Ab42. We
investigated the changes in transcriptome profiles over time for both
control flies and those expressing Ab42. The use of such an early
onset model allowed us to distinguish between changes in gene
expression due to AD and those due to ageing.
Results
Transcriptome analysis of AD and control flies over time. To
investigate the differences between the processes of ageing and AD
we used microarrays to measure changes in gene expression over
time in control and Ab42-expressing flies (hereafter referred to as
Ab flies). The Ab flies used in these experiments carried 2 copies of a
transgene expressing human Ab42 (elavGAL4.UAS-Ab42), the 2 3
Ab42 model. Ab flies have a much shorter lifespan with a median
survival (50% flies still alive) of 23 vs. 63 days in control flies (see
Supplementary Fig. S1, for the climbing, survival, and molecular
phenotypes of Ab flies used in our experiments). Therefore, in
order to clearly distinguish Ab and age-related changes in gene
expression, we compared Ab and control flies using a two-pronged
strategy. In the first experiment, we age-matched flies according to
their chronological age and extracted RNA samples from fly heads at
days 3, 10 and 20 for both Ab flies and the control cohort (Fig. 1). At
these time points the survival of the flies is approximately 100% and
so we can match samples from flies according to their chronological
age.
Beyond day 20, mortality in Ab flies begins to increase and it is
conceivable that increasing mortality itself could be associated with
changes in gene expression. To compare gene expression changes
associated with the increase in mortality in Ab flies with those assoc-
iated with normal ageing, we continued to extract RNA samples from
Ab and control flies but at different times such that the % survival of
each group was the same (80% and 20% survival, this corresponded
to days 21, and 25 in Ab flies and days 56, and 68 for control flies).
We used this data for a separate analysis of the gene expression
changes over time according to survival. All RNA samples were
extracted from one cohort of flies (see Methods) to reduce the effect
of biological variability, but the age-matched and survival-matched
samples were analysed separately and we refer to them as separate
experiments. The day 3 (100% survival) sample is common to both
analyses.
Analysis of the gene expression profiles from the two experiments
(see Methods for details) identified 233 (day-matched) and 636 (sur-
vival-matched) differentially expressed genes, with a total of 712
genes combined (and an overlap of 157 genes, see Supplementary
Table S1 online). We clustered average expression levels of the sig-
nificantly differentially expressed genes using fuzzy c-means cluster-
ing (R mfuzz package)12,13 for each of the two experiments (Fig. 2:
‘‘a–e’’ day-matched and ‘‘f–j’’ survival-matched).
In each experiment, we identify two categories of clusters. The first
category of clusters (for both experiments), represents genes that are
differentially up- or down- regulated in Ab flies compared to con-
trols, but do not change with time (Clusters ‘‘b’’, ‘‘c’’, ‘‘f’’ and ‘‘i’’; 69,
47, 95 and 85 genes respectively – note that as fuzzy clustering is used,
the number of genes assigned to each cluster does not total the
number of significant genes). These genes presumably represent a
direct response of the flies to the Ab aggregation insult. By contrast
the second category of expression profile clusters, for both experi-
ments, represents genes with expression profiles that change over
time (clusters ‘‘a’’, ‘‘d’’, ‘‘e’’, ‘‘g’’, ‘‘h’’ and ‘‘j’’ - 46, 35, 39, 121, 169, and
171 genes respectively). Based on these clusters, it appears that very
few genes change expression over time in Ab flies compared to con-
trols, and that changes over time are more pronounced in control
flies.
We therefore analysed the expression profiles of all genes present
on the array for Ab and control flies separately (see Methods) to
identify all genes that change expression significantly over time in
each group. For Ab flies we identified 144 genes, whereas for control
flies we identified 612 (with an overlap of 90 genes, Supplementary
Table 1 online). For both Ab and control flies, the genes changing
over time were involved in similar pathways based on enriched Gene
Ontology (GO) terms, in particular immune response andmetabolic
processes (data not shown). Therefore we conclude that the dysre-
gulation is gene specific rather than pathway specific. For each of
these genes, we tested the correlation between gene expression level
and percent survival. Of the 144 genes whose expression level
changes significantly over time in Ab flies, there were only four
(IM23, CG14933, CG7830, CG8036) whose expression level corre-
lated with survival (Pearson’s Product Moment Correlation
Coefficient (r), 0.8# r#20.8). There is little information available
on the function of these four genes, so we are unable to explain why
the expression of these genes in particular correlates with the
decrease in survival. Based on the fact that only 144 genes change
expression over time in Ab flies, we conclude that the transcriptional
response to Ab expression in our fly model is mostly not age
dependent.
By contrast, 195 out of 612 genes changing expression correlated
with the decreased survival in control flies using the same threshold.
Of the four genes whose expression correlated with survival in Ab
flies, two were also correlated in controls (CG14933 and IM23) and
the expression of both genes increased over time for both Ab and
control cohorts. We therefore conclude that there is no common
mortality signature (i.e. genes that change in expression over time
in both AD and control cohorts and whose expression levels corre-
lated with survival in both), and that the gene expression changes
occurring with normal ageing are distinct from those associated with
Ab expression in Drosophila. At the transcriptional level, the Ab
expression-associated signature is a constant change in the relative
level of transcription of a certain set of genes over all time points
measured, rather than the signature of ageing that manifests as a
change in the level of transcription over time.
The 612 genes whose expression changes significantly over time in
our control flies constitute a transcriptional signature of normal
ageing in control flies. We compared this list of genes to a previous
ageing study in Drosophila14. 44% (282/612) of genes changing
Figure 1 | Schematic representation of the experimental design. (a) RNA
samples are extracted from both control and AD flies at the same time in
days. (b) RNA samples are extracted from both AD and control flies at the
same % survival, which is a different time in days for each after 100%
survival.
www.nature.com/scientificreports
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expression with age in our control flies were also identified as ageing-
related genes by Landis et al14, significantly more than expected by
chance (hypergeometric test for enrichment, p , 1 3 10e-19).
Furthermore, 63% of our 195 ageing signature genes for which
expression level correlated with decreased survival with age were
identified as ageing genes in the same study14 (hypergeometric test
for enrichment, p, 1 3 10e-22). An analysis of the correlated genes
for the control cohort using the Flymine database15 revealed that the
Figure 2 | Clustering of changes in gene expression in Control andAb flies. (a–j). Clustering of gene expression changes in Control (black) and AD (red)
using Mfuzz. Bold lines represent cluster centroids, thin lines are average expression profiles for all cluster members plotted against equivalent time
points (a–e) based on day (days 3, 10 and 20 for both Ab and control flies, all approximately 100% survival) and (f–j) based on % survival of the flies
(days 3, 21 and 25 (Ab flies) or days 3, 56 and 68 (control flies), corresponding to 100%, 80% and 20% survival in each case).
www.nature.com/scientificreports
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pathways in which these genes are involved are significantly enriched
in a number of pathways and GO annotations related to xenobiotic
metabolism, glutathione metabolism and immune response path-
ways16,17. This is consistent with current theories of ageing18–20. The
transcriptional changes associated with ageing in our control flies are
therefore consistent with expected changes with age in Drosophila,
both at the single gene and pathway level. The fact that our analysis
produces expected results for control flies lends weight to the con-
clusions drawn from our analysis of the Ab flies.
We performed Principal Components Analysis (PCA) of the
expression data (Supplementary Fig. S2) and found that, while across
the first three sample points Ab and control groups cluster together,
in the final two (where samples did not have the same age in days)
they do not, confirming that the downstream effects of Ab expression
in this model are not similar to normal ageing, at least at the level of
transcription. Supplementary Table S1 online lists all the differenti-
ally expressed genes, what method determined their significance, the
cluster to which they belong for both experiments, their Pearson
correlation with survival and their normalised expression level (see
Methods) for each data point and for each of the replicates.
Oxidative stress-related changes in gene expression with AD. The
transcript most highly up-regulated (,8-fold; Fig. 3a) in Ab flies in
our experiments was Sod3 (CG9027) which encodes an extracellular
Cu/Zn superoxide dismutase21. In Drosophila there are 4 Sod3
transcripts (and 3 protein products), and two of these, Sod3-RD
and Sod3-RE are specifically up-regulated in the Ab flies (see
Fig. 3a for Sod3-RD/RE and Fig. 3b for Sod3-RA/RB profiles).
Superoxide dismutase enzymes have recently been linked to inflam-
mation, with Sod3 proposed to contribute to this process both by
scavenging free radicals and also, more directly, by affecting immune
responses and signal initiation22. Interestingly, in 2009, before Sod3
had been discovered in flies21, Rival et al10 showed that overexpres-
sion of Sod1 was associated with a decrease in lifespan in Ab flies.
Cyp6a20, encoding a cytochrome P450 enzyme, was another gene
with significantly altered expression in Ab flies compared to control
flies. We found that Cyp6a20 expression was significantly reduced in
Ab flies in an age- independent manner (see Supplementary Table S1
for expression data). Cyp6a20 was also identified in a genetic screen
as a modifier of the survival phenotype in Ab flies10 and cytochrome
P450s have previously been identified as being a group of enzymes
that are up-regulated with age23,24. On the other hand, genes such as
Prx2540-2 (Fig. 3c), encoding peroxidases involved in the clearance
of hydrogen peroxide25, appear to change with time in control flies.
This change was not observed in Ab flies. Increased expression with
age in control, but not Ab, flies was also observed for genes involved
in glutathione metabolism, for example several of the glutathione-S-
transferases increased expression over time only in control flies
(Supplementary Table S1). Interestingly, one member of this family,
GstE9, did increase expression over time in Ab flies. We again con-
clude that the same processes are important in Ab toxicity and age-
ing, but with different specific genes affected by each process.
Immune response-related changes in gene expression with AD.
Two important processes that showed significantly altered gene
expression profiles in our AD model are the innate immunity and
defence response pathways. Many genes in these pathways normally
become up-regulated during ageing23,26. In control flies, increased
expression with age was observed for genes involved in the antibac-
terial humoral response14, such as Dpt, CecA1, CecA2 and Drs.
Figure 3 | Expression profiles of individual genes in Control and Ab flies. Gene expression profiles of RNA from heads from Control (black) and Ab
(red) female mated flies at 6 time points during adulthood. Time points correspond to days 3, 10 and 20 (100% survival) in both control and Ab flies and
at 56 (21), and 68 (25) days in Control (Ab) flies that correspond to 80% and 20% survival, respectively. Average gene expression levels of four biological
replicates (except time point 3 and 5 which are the average of 3 biological replicates, see Methods) 6 s.e.m. plotted. (a) Sod3-RD and Sod3-RE
(b) Sod3-RA and Sod3-RB (c) Prx2540-2 (d) CG14715 (e) PGRP-SC1b (f) sec31.
www.nature.com/scientificreports
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Similar changes were not observed in Ab flies. For example, immune
response genes, such as that encoding the proteoglycan recognition
protein PGRP-SC1b were significantly altered in our experiment
(Fig. 3e), with increased transcript levels in Ab flies vs. controls at
all time points. PGRP-SC1b is a catalytic PGRP that is likely to be
involved in down-regulation of the Imd innate immunity pathway in
response to injury27.
Cellular transport and chaperone related changes in gene expres-
sion with AD. Intracellular transport, specifically endocytic proces-
sing, has been implicated in AD using GWA studies for sporadic
AD28. In our study, sec31, a gene coding for an essential compo-
nent of the COPII coat for ER to Golgi transport29, was increased
in expression in Ab flies compared to controls (Fig. 3f). CG14715,
another gene implicated in intracellular transport and protein
folding, encodes the Drosophila ortholog of FKBP2/FKBP13, a
prolyl-isomerase thought to function as an ER chaperone30,31. The
expression of CG14715 was down-regulated in an age-independent
manner in the Ab flies (Fig. 3d).
Identifying modifiers of the Ab phenotype using gene-specific
RNAi. Our microarray analysis identified significant expression
changes (between control and Ab flies) in 712 genes. These genes
are potential modifiers of the Ab phenotype. In order to determine
whether the observed expression changes are relevant to the onset or
development of the disease or whether they are simply correlative, we
manipulated the levels of four of these genes in the Drosophila AD
model (Data summarised in Table 1). We chose two genes that are
highly up-regulated in an age-independent manner in Ab flies: Sod3,
which was identified as the most differentially expressed gene
between the Ab and control flies (,8 fold increased levels in Ab
flies, Fig. 3a) and PGRP-SC1b (,2 fold increased levels in Ab flies,
Fig. 3e). These genes are involved in oxidative stress and innate
immunity, respectively. We also investigated sec31, encoding a
protein involved in intracellular transport (,1.5 fold increased
levels in Ab flies, Fig. 3f) and CG14715, coding for a putative ER
chaperone (,1.7 fold decreased levels in Ab flies, Fig. 3d).
In these experiments, we used a modified version of the fly AD
model (elavGAL4. UAS- Ab42arc) in which flies expressed a single
copy of the Ab peptide containing the familial E22G (arctic) muta-
tion that increases the aggregation propensity of the Ab42 peptide32.
It has been shown previously11,32,33 that these models are equivalent
and that their effect on the flies’ lifespan is proportional to the
aggregation propensity of the Ab variant. Luheshi et al. (2010) inves-
tigated the effect of mutations (including the arctic mutation) in the
sequence of Ab42 and showed that the aggregation propensity and in
vivo toxicity as quantified by locomotor and survival assays were
correlated. Finally, as shown below, the two models show similar
changes in expression of specific genes. Although, we cannot exclude
the possibility that the brain pathology due to expression of the
alternative Ab transgenes is different, this evidence suggests that they
have similar effects.
We confirmed the up-regulation of Sod3 using qRT-PCR. Sod3 has
4 alternative transcripts. Increases in Sod3mRNA levels in themicro-
array experiment (neuronal expression of two copies of Ab42) were
specific to two transcripts, Sod3-RD and Sod3-RE. qRT-PCR quan-
tification of total Sod3 levels suggested a 50% increase in Sod3 tran-
scription in the heads of Ab flies at day 20 (Fig. 4a). However,
transcript-specific primers showed a much larger increase in Sod3-
RD (,100-fold) and Sod3-RE levels (,20-fold) confirming the array
data (Fig. 4b, 4c). In Abarc flies (expressing neuronal Ab42arc pep-
tide), total Sod3 mRNA levels were actually decreased (Fig. 4d).
However as in the 2 3 Ab42 flies, both Sod3-RD and Sod3-RE
mRNA levels were significantly increased in heads from Abarc flies
(Fig. 4e, 4f). Thus, both Ab andAbarc flies show a specific increase in
the levels of Sod3-RD and Sod3–RE transcripts.
As Sod3 transcript levels are also increased in Abarc flies, we tested
whether reducing Sod3 levels using RNAi could ameliorate the Ab
phenotype. Ubiquitous RNAi against Sod3 resulted in effective
knock-down of total Sod3 expression levels in head mRNA (down
to 10% of control) and substantial knock-down of Sod3-RD and
Sod3-RE expression levels (down to 30–40% of control: Supplemen-
tary Fig. S3), confirming that indeed the Sod3-RNAi line is substan-
tially knocking down Sod3 transcript levels.
Targeting Sod3RNAi specifically to the nervous system resulted in
a consistent (though not statistically significant) decrease in total
Sod3 RNA levels in head RNA from both Sod3 RNAi control and
Abarc flies (vs. non-RNAi controls, Fig. 4d–f). Since Sod3 levels were
measured from whole head RNA extracts, which also include other
cell types apart from neurons, our measurement of total head Sod3
mRNA is likely to be an underestimate of the actual knock-down in
the nervous system.
Sod3 RNAi improved climbing (Fig. 4g and Supplementary Fig.
S3) and survival in AD flies; median survival for Abarc Sod3-RNAi
flies was 35 days vs. 31 days for control Abarc flies (Log-rank test, P,
0.0001: Fig. 4h and Supplementary Fig. S3), and this appeared to
correlate with significantly decreased Sod3-RE mRNA levels
(Fig. 4f). Ubiquitous knock-down of Sod3 has previously been
reported to be detrimental for Drosophila lifespan21. However, we
did not observe any significant effect of nervous system-specific
Sod3-RNAi in control (i.e. no Abarc) flies (Fig. 4g and 4i and
Supplementary Fig. S3). Thus, ablating Sod3 up-regulation in
Abarc flies ameliorates the Ab phenotype.
We next took a similar approach to investigating PGRP-SC1b. In
the microarray study, PGRP-SC1b RNA levels were increased ,2-
fold in Ab flies (Fig. 3e); moreover, qRT-PCR, showed a similar
increase (Fig. 5a). In Abarc flies (expressing neuronal Ab42arc pep-
tide), PGRP-SC1b RNA levels were increased,10-fold in head RNA
(compared to control flies, Fig. 5b). Ubiquitous RNAi against PGRP-
SC1b resulted in effective knock-down of PGRP-SC1b expression
levels (down to 30% of control: Supplementary Fig. S5). Targeting
RNAi against PGRP-SC1b to the nervous system resulted in
improved climbing (Fig. 5d) and survival (median survival for
Abarc PGRP-SC1b RNAi flies was 38 days vs. 36 days for Abarc,
Log-rank test, P , 0.0001, Fig. 5f) flies compared to their (non-
RNAi) controls. However, we did not observe any significant effect
of nervous system-specific PGRP-SC1b-RNAi in control (i.e. no
Abarc) flies (Fig. 5c, 5e and Supplementary Fig. S4).
RNAi against CG14715 (which encodes a prolyl-isomerase
thought to function as an ER chaperone30,31) in the fly nervous system
of Abarc flies resulted in a significant increase in survival (median
survival for two Abarc CG14715 RNAi lines was 34 days vs. 31 days
for Abarc, Log-rank test, P, 0.0001; Supplementary Fig. S5) but no
improvement in climbing ability (compared to non-RNAi controls;
Supplementary Fig. S6). By contrast, overexpression of CG14715, in
Abarc flies, resulted in a significant increase in climbing ability in
early adulthood but had no effect on survival (Supplementary Fig.
S5). In control (non-Abarc) flies, RNAi knock-down or overexpres-
sion of CG14715 resulted in either no effect or a slight deficit in
climbing ability; neither treatment affected survival (Supplemen-
tary Fig. S5). Thus manipulating CG14715 expression can modify
the Ab phenotype, but the effect is complex.
Overexpression or RNAi knock-down of sec31 in the fly nervous
system resulted in decreased climbing ability and longevity in control
(non-Abarc) and either no, or a negative, effect in Abarc flies.
(Supplementary Fig. S6). The sec31 protein is an essential compon-
ent of the COPII tracking complex29 so it likely that sec31 levels are
critical for normal cellular function. Thus it is unclear whether sec31
has any specific modifying effect on the Ab phenotype.
These results suggest that modifying expression of Sod3, PGRP-
SC1b and CG14715 in Ab flies can suppress the locomotor and
survival defects associated with toxic Ab42 expression.
www.nature.com/scientificreports
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Discussion
In this study, we have used time-course transcriptomic analysis to
identify 712 D. melanogaster genes that are differentially expressed
between Ab-expressing and control flies. Our results suggest that
Ab-expressing flies are more similar to young than to old control
flies. Since Ab and control flies remained transcriptionally distinct as
their mortality increased, we therefore conclude that the expression
of Ab in this model does not equate to an increased rate of ageing.
Cluster analysis revealed that differentially expressed genes can be
separated into those that change expression over time and those
whose expression is constant. These results are consistent with the
very aggressive nature of the model in which very high levels of Ab
are expressed at all times. We suggest that any change at the molecu-
lar level that correlates with the phenotype in the Ab flies lies down-
stream of the transcriptome and that, by day 3, the Ab flies are
already in an essentially ‘‘terminal’’ transcriptional state. In this state,
Figure 4 | Sod3 levels in Ab flies and effects of Sod3 RNAi on Sod3 expression, locomotion and survival. (a–c). Levels of Sod3 transcripts in head RNA
from Ab (elavGAL4 . UAS-Ab42 3 2) and control (elavGAL4/1) female mated flies at day 20 measured by qRT-PCR and plotted relative to Act5C
mRNA levels, in arbitrary units, represented relative to levels in control (set to 1). (a) Total Sod3 mRNA levels (primers against A, B, D, E common
transcript). (b) Sod3-RD mRNA levels. (c) Sod3-RE mRNA levels. (d–f), Levels of Sod3 transcripts in head RNA from Control (elavGAL4/1), Abarc
(elavGAL4. UAS-Ab42arc), Control 1 Sod3 RNAi and Abarc 1 Sod3 RNAi female mated flies at day 7 measured by qRT-PCR and plotted relative to
Act5C mRNA levels, in arbitrary units, represented relative to mRNA levels in Control (set to 1). qRT-PCR analysis: n 5 3 replicates, mean 6 s.e.m.
plotted. mRNA levels between groups compared using two-tailed Student’s t-test (f-test for equal variance). (d) Total Sod3 mRNA levels. (e) Sod3-RD
mRNA levels. (f) Sod3-REmRNA levels. (g) Climbing performance of Control (elavGAL4/1), Abarc (elavGAL4.UAS-Ab42arc), Control1 Sod3 RNAi
and Abarc 1 Sod3 RNAi mated females at different time points at 24uC. n 5 3 (3 replicates, 10 flies/replicate). Performance indices (see Methods)
betweenControl andControl1 Sod3RNAi andAbarc andAbarc1 Sod3RNAiwere compared at each time-point using two-tailed Student’s t-test (f-test
for equal variance). (h) Survival curves of Abarc (n5 105, median 5 31, P, 0.0001 vs.Control) and Abarc1 Sod3 RNAi (n5 97, median survival5 35,
P, 0.0001 vs.Abarc)mated females at 25uC. (i) Survival curves of Control (n5 93;median survival5 66) andControl1 Sod3RNAi (n5 102;m5 66, P
5 0.5280 vs. Control) mated females at 25uC. Comparison of survival curves was carried out using the Log-rank test. P values: *, P, 0.05; **, P, 0.01;
***, P , 0.0001.
www.nature.com/scientificreports
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Figure 5 | Effects of PGRP-SC1b RNAi on PGRP-SC1b expression, locomotion and survival. (a) PGRP-SC1b mRNA levels in head RNA from Ab
(elavGAL4.UAS-Ab42 3 2) and control (elavGAL4/1) mated female flies at day 20measured by qRT-PCR and plotted relative to Act5CmRNA levels,
in arbitrary units, represented relative to mRNA levels in elavGAL4/1 flies (set to 1). n 5 3 replicates, mean 6 s.e.m. plotted. mRNA levels between
groups compared using two-tailed Student’s t-test (f-test for equal variance). (b) Levels of PGRP-SC1bmRNA in head RNA fromControl (elavGAL4/1),
Abarc (elavGAL4.UAS-Ab42arc), Control 1 PGRP-Sc1b RNAi, and Abarc 1 PGRP-SC1b RNAi from flies at day 7 measured by qRT-PCR. n 5 3
replicates, mean 6 s.e.m. plotted. mRNA levels between groups compared using two-tailed Student’s t- test (f-test for equal variance). (c) Climbing
performance of Control, andControl 1 PGRP-Sc1b RNAi, at different time points at 24uC. Performance indices were compared at each time-point using
two-tailed Student’s t-test (f-test for equal variance). (d) Climbing performance of Abarc andAbarc1 PGRP-SC1b RNAi at different time points at 24uC.
Performance indices were compared at each time-point using two-tailed Student’s t-test (f-test for equal variance). (e) Survival curves of Control (n 5
119,median5 73) andControl1 PGRP-SC1b RNAi (n5 77,m5 74.5, P5 0.1825 vs.Control) female flies at 25uC. (f) Survival curves of Abarc (n5 91,
median5 36, P, 0.0001 vs.Control) andAbarc1PGRP-SC1bRNAi (n5 77,m5 38, P, 0.0001 vs.Abarc) female flies at 25uC.Comparison of survival
curves was carried out using the Log-rank test. P values: *, P , 0.05; **, P , 0.01; ***, P , 0.0001.
www.nature.com/scientificreports
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certain pathways such as the oxidative stress response pathway
appear to be dysregulated and drive degeneration, which is expressed
as both decreased locomotor activity and increased mortality.
We have further investigated some of the genes that were consis-
tently over expressed in Ab flies and we identified two modifiers of
Ab toxicity: Sod3 and PGRP-SC1b. In particular we found that
increased levels of two Sod3 transcripts in Ab flies were not accom-
panied by a compensatory increase in expression of either catalase or
peroxidases. An imbalance in the relative levels of these three types of
enzymes may result in an increased level of toxic H2O2 in Ab flies,
contributing to disease pathology. The expression of an RNAi for
Sod3 resulted in a reduction in mRNA levels for at least one Sod3
transcript, and was accompanied by improved locomotor ability and
survival in Ab, but not control, flies. This suggests that decreasing
Sod3 enzyme levels in our Ab flies alleviated a toxic H2O2 overload.
Rival et al10, found similar results regarding the toxicity of H2O2. In
particular, they observed increased survival of Ab flies when a dom-
inant negative mutant Sod1 was expressed and reduced survival
when wild-type Sod1 was expressed. By contrast, they found that
the median survival was increased when Cat (encoding catalase)
was overexpressed, suggesting that overproduction of H2O2 by the
Sod1 enzyme can overwhelm catalase resulting in toxicity and a
decrease in lifespan of the Ab flies. Moreover, a previous study34 in
C. elegans showed that loss of the sod-4 gene, (the C. elegans ortholog
of Sod3) had no effect on lifespan in wild-type worms, but increased
the survival of daf-2 (insulin receptor) mutants. Doonan and collea-
gues34 suggested that the SOD-4 enzyme may be generating H2O2,
which acts as a signallingmolecule and activates IIS (insulin/IGF-like
signalling) by inactivating redox-sensitive phosphatases35; conse-
quently, its loss in IIS mutants would enhance their long-lived
phenotype. Increased H2O2 in Ab flies could also act as a signal.
Thus, by reducing Sod3 enzyme levels, we would decrease both the
toxic overload and affect the signalling role of H2O2 to enhance life-
span. There have also been a number of reports on the activation of
autophagy by H2O2 through the PI3K/Beclin1 and the PI3K/Akt/
mTOR pathways36. In the case of PGRP-SC1b, it is not clear why
RNAi results in an increase in lifespan and improved locomotor
abilities in AD flies. We speculate that it could be due to a dysregula-
tion of the pathway, similar to what we observed for Sod3.
The comparative analysis of gene expression between AD and
ageing revealed changes at the single gene level, rather than the
pathway level. Nevertheless, if the individual genes that are regulated
very differently in Ab flies vs. wild-type controls are considered, a
number of important inferences may be made concerning AD. One
particular example is the oxidative stress pathway, which is up-regu-
lated with age in control flies (in our experiment and Landis et al)14.
In the wild-type fly, manipulating cellular antioxidant defences
(using transgenes) is not necessarily beneficial or detrimental to
the health of the organism18. In other words, physiological levels of
ROS can be dealt with by the insect’s powerful enzymatic and non-
enzymatic detoxification routes. However, mitochondrial dysfunc-
tion is observed in AD and this may be exacerbated with age37;
therefore it is possible that ROS generated as a consequence of this
mitochondrial dysfunction overwhelms cellular detoxification
pathways.
It is becoming clear that the cascade of events that originates from
the aggregation of Ab and tau involves major stress response path-
ways, and all these stress pathways appear to be inter-related.
However, their co-regulation and inter-relationships have been
poorly characterised to date. In this study, we observed the dysregu-
lation of a number of genes that belong to pathways that appear to be
related, even though we were not able to assess their precise regula-
tory relationship. In all, this study has allowed us to investigate the
processes that change in Ab flies and dissect these from the processes
that change with normal ageing. We observed a large number of
dysregulated processes in AD flies. In particular, we highlight a
number of genes involved in redox stress, innate immune response
and pathogen defense response and intracellular transport. We have
shown that either knocking-down or over-expressing some of these
genes increased lifespan and improved locomotor (climbing) ability
in Ab flies compared to control flies. This suggests that the processes
of oxidative stress and the immune response are likely to play an
important role in the disease. The insights into time/age-dependent
gene expression levels in AD that have been gained using an insect
model may prove valuable in the design of strategies to combat this
economically and socially important disease.
Methods
Fly stocks and maintenance. The UAS-Ab42-51D and UAS-Ab42arc-51D flies were
generated using the PhiC31 method as previously described38. ElavGAL4C155 and
tubGAL4 were used for neuronal-specific expression and ubiquitous expression of
transgenes respectively. For microarray experiments, w1118, elavGAL4 . UAS-Ab42-
51D (32 copies) flies and controls w1118, elavGAL4/1; 51D (32 copies, empty
insertion site) were used. For RNAi experiments, we replaced UAS-Ab42-51D (32
copies) flies with flies carrying a single UAS-Ab42arc-51D transgene. The presence of
one, as opposed to two, transgenes in this line facilitated the use of the other
transgenes required in these experiments. Ab42 carrying the E22G (arctic) mutation
was used, since a single copy of the wildtypeAb42 transgene was found not to result in
a significant locomotor or survival defects in our experiments. The phenotypes caused
by expression of the wild-type Ab transgene and the arctic Ab transgene are
quantitatively and qualitatively similar, as can be seen from the relative effects of each
transgene on locomotor performance and survival (Supplementary Fig. S1). Median
survival for the arctic model is 31 days in the Ab flies compared to 24 days in the 2 3
Ab42model and 66 days in control flies. For the RNAi experiments,w1118, elavGAL4.
UAS-Ab42arc-51D flies were used and controls, w1118, elavGAL4/1;51D (empty
insertion site). In these experiments, female virgin w1118; 51D or w1118; UAS-Ab42arc-
51D flies were crossed to w1118, elavGAL4 . UAS-RNAi males. In the PGRP-SC1b
experiments (RNAi insertion on chromosome X), female virgin w1118, UAS-PGRP-
SC1b RNAi flies were mated to w1118, elavGAL4 . UAS-Ab42arc-51D/CyO or w1118,
elavGAL4; 51D/CyO flies to generate the experimental flies. RNAi and over-
expression lines were obtained from the VDRC or Bloomington stock centers. The
lines used were Sod3-RNAi (VDRC# 37793, w1118; P{GD4801}v37793), PGRP-SC1b
RNAi (VDRC #51237, w1118, p{GD5490} v51237), sec31-RNAi (VDRC #35867, w1118;
P{GD13867}v35867), sec31-OE (Bloomington #22308, y1 w67c23; P{w[1mC]
y[1mDint2] 5 EPgy2}sec31 [EY19759] ), CG14715 RNAi, (VDRC #104124 w1118;
P{KK104150}VIE-260B; #12828, w1118; P{GD4788}v12828), CG14715 OE
(Bloomington #32608, w1118; P{w[1mC] 5 EP}CG14715 [G6908]). All stocks were
backcrossed for at least 6 generations into the w1118 background prior to carrying out
the experiments. Flies were raised and maintained on cornmeal medium (87.5 g/l
dextrose, 87.5 g/l maize, 19 g/l yeast). Stocks were maintained and experiments were
conducted at 25C on a 12512 hours light/dark cycle at constant humidity.
Table 1 | Differentially expressed genes selected for follow up experiments and summary of results
Gene Function Expression Profile Effect of RNAi in this work
Sod3-RD, Sod3-RE Extracellular Cu/Zn
superoxide dismutase21,22,42
Over-expressed in Ab
flies. Fig. 3a
Improved climbing and survival in Abarc flies. No effect on survival of
control flies, slight increase in climbing performance. Figure 4
PGRP-SC1b Innate immune response27 Over-expressed in Ab
flies. Fig. 3e
Improved climbing and survival in Abarc flies. No effect in control flies.
Figure 5
sec31 ER to Golgi transport29 Under-expressed in Ab
flies. Fig. 3f
Increased survival of Abarc flies, no effect on climbing ability. No effect on
survival or climbing performance in control flies. Supplementary Figure S6
CG14715 Intracellular transport and
protein folding30,31
Over-expressed in Ab
flies, Fig. 3d
Negative effect on climbing and survival in both control and Abarc flies.
Supplementary Figure S5
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Microarray methods. RNA was extracted from 50 fly heads according to standard
Trizol (Invitrogen, Paisley, UK) protocols. FlyChip_long_oligonucleotide_003
(FL003) - INDAC (Flychip, University of Cambridge, http://www.flychip.org.uk/)
microarray chips were used for the expression analysis (GEO Platform GPL14121).
These chips have been used extensively for Drosophila expression profiling and
include 14,444 transcript-specific oligonucleotides (70mers) and various controls.
Samples were labelled and hybridised according to standardised protocols (http://
www.flychip.org.uk/protocols/). Four replicates were used for each sample (w1118,
elavGAL4 . UAS-Ab42-51D (32 copies) flies and controls w1118, elavGAL4/1; 51D
(32 copies, empty insertion site) and five time points. Time points used
corresponded to days 3,10 and 20 (100% survival in both Ab and control flies) and
days 21, 25 (Ab flies) or days 56, and 68 (control flies), corresponding to 80% and 20%
survival in each case) Samples were matched on arrays by time point. The data
discussed in this publication have been deposited in NCBI’s Gene Expression
Omnibus and are accessible throughGEOSeries accession numberGSE48681 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc5GSE48681).
Analysis of microarray data. The raw data were filtered to remove any probes that
were rejected in over 50% of samples and were quantile-normalised across all arrays
using Limma39. One array (hybridised to a time point 3 sample) was removed from
further analysis at this stage. Any missing values were imputed using the impute
package (R package version 1.32.0. http://CRAN.R-project.org/package5impute).
Differentially expressed genes were identified using twomethods. Firstly, Limma was
used to fit a linear model to the entire time course and genes identified as significantly
differentially expressed were those with an F statistic p-value , 0.05 following FDR
correction. Secondly, the maSigPro40 package was used to identify genes with
significantly (p , 0.05 after FDR correction) different changes in expression over
time. For both methods, the samples were matched by % survival. The results from
maSigPro and Limma analysis were combined and the expression of each significant
gene averaged over all replicates and standardised (to have a mean of 0 and standard
deviation of 1). These data, matched by % survival, were then clustered using the R
package Mfuzz13, which implements fuzzy c-means clustering12. Two clustering
parameters are required; the fuzzifierm and the number of clusters c. The appropriate
value of m was determined using the Mfuzz function ‘‘m.estimate’’, c was determined
by examining the effect of c on the minimum centroid distance13,41.
maSigPro40 was used to identify genes changing expression over time in Ab and
control flies separately (p, 0.05 after FDR correction). Each of these genes was tested
for correlation with % survival using a Pearson Product Moment Correlation
Coefficient in R.
Lifespan. Flies were reared at standard density, allowed to mate for 24 h, sorted by
sex, and then transferred to experimental vials at a density of ten female flies per vial.
Flies were transferred to fresh vials three times aweek, and deaths were scored three to
five times a week. Lifespan data were subjected to survival analysis (Log-rank tests)
using GraphPad Prism 5 Software (GraphPad Software, Inc).
Locomotor/climbing assays. The locomotor ability of the flies was assessed in a
1 min negative geotaxis assay as previously described9. Ten flies were placed in a
plastic 25-ml pipette and knocked to the bottom of the pipette. The number reaching
the 10 ml line of the pipette (ntop) and the number remaining at the bottom (below the
2-ml line) (nbottom), after 1 min, were measured. The performance (mobility) index
was then calculated as (ntop 2 nbottom 1 ntotal)/2ntotal. Three to four replicates were used
per genotype. Climbing in each pipette was assessed three times and the average
performance index for each pipette calculated. Assays were carried out in a well-lit
room at a temperature of 23–24uC. Themean of the independent biological replicates
for each genotype was plotted with the s.e.m.. Two-tailed Student’s t-tests (f-test for
equal variance) were used to identify significant differences at specific time points.
qRT-PCR.Total RNAwas extracted from20 adult heads per genotype using standard
Trizol (Invitrogen, Paisley, UK) protocols. RNA was DNase-treated (Fermentas,
Thermo Scientific, UK) and cDNA was prepared using oligo-d(T) primers and a
Promega Reverse transcription kit (#A3500) according to the manufacturer’s
protocol (Promega, Southampton, UK). qRT-PCR was performed using a Biorad iQ
machine and KAPA (KK4608) SYBR green PCR master mix (Biorad, Hemel
Hempstead, UK). Relative quantities of transcripts were determined using the relative
DDCt method and normalised to Act5C. Two to five independent RNA extractions
were used for each genotype. Primer sequences are available upon request.
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